ロード中...
Neoadjuvant Therapy – What Have We Achieved in the Last 20 Years?
Neoadjuvant chemotherapy is the standard of care for patients with large, inoperable tumors or inflammatory breast cancer, but it is also increasingly considered for women with operable disease. Several randomized trials have demonstrated that anthracycline- and taxane-containing regimens in operabl...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
S. Karger GmbH
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3290030/ https://ncbi.nlm.nih.gov/pubmed/22419894 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000335347 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|